General form of registration statement for all companies including face-amount certificate companies

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical)

v3.21.1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical) - Convertible Notes Payable One [Member]
12 Months Ended
Dec. 31, 2020
USD ($)
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Common stock issuable upon conversion, shares | shares 6,227,340
Common stock issuable upon conversion | $ $ 1,294,268
Beneficial ownership limitations percentage 4.99%